## BACKGROUND. The differentiation between malignant mesothelioma and adenocarcinoma based on morphology alone can be a diagnostic challenge. The majority of the available antibodies recognize molecules expressed by adenocarcinoma whereas to the authors' knowledge specific markers for mesothelial
Immunocytochemistry in the differential diagnosis of serous effusions
✍ Scribed by Lozano, Maria D. ;Panizo, Angel ;Toledo, Gemma R. ;Sola, Jesus J. ;Pardo-Mindán, Javier
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 239 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The authors gratefully acknowledge the expert technical assistance of L. Martinez in immunocytochemistry, and M. Maset in handling and staining the specimens.
📜 SIMILAR VOLUMES
The use of ancillary techniques to aid in the diagnosis of metastatic carcinoma in serous effusions has been the subject of numerous studies. In this article, we study 35 cases of malignant effusions (metastatic adenocarcinoma) and 20 benign effusions using a panel of immunohistochemical markers to
The distinction between malignant and benign serous effusions continues to be a challenging and a frequent problem to cytopathologists. Recently, immunostains employing various antibodies have improved the diagnostic accuracy of malignant effusions. We investigated the usefulness of Ki67 (MIB1) anti
Schizophrenia is considered to be a heterogenous disorder. Different etiopathological mechanisms can be attributed to a similar clinical picture as described in DSM-111-R criteria. We present a case of a young man diagnosed on different occasions as schizophrenic with mild mental retardation. Clinic